Compare Bristol-Myers Squibb Co (BMY) vs Teucrium Wheat Fund (WEAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Teucrium Wheat Fund — how do they compare? Bristol-Myers Squibb Co trades at $64.69 (market cap $130.12B), while Teucrium Wheat Fund trades at $24.05. The key difference: Bristol-Myers Squibb Co pays a 3.96% dividend while Teucrium Wheat Fund pays none, and Bristol-Myers Squibb Co is trading nearer its 52-week high, Teucrium Wheat Fund nearer its low. Which is the better fit depends on your goals.
| BMY | WEAT | |
|---|---|---|
Market Cap | $130.12B | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $65.89 | $26.00 |
52-Week Low | $42.60 | $19.88 |
Enterprise Value | $164.11B | — |
Dividend Yield | 3.96% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Teucrium Wheat Fund
WEAT is a commodity ETF that provides exposure to the price of wheat futures. It employs a laddered strategy across multiple benchmark contracts to mitigate the effects of contango and roll costs inherent in agricultural futures trading.
Read more on WEAT →
